71st Annual Meeting of the Florida Urological Society (FUS)

71st Annual Meeting of the FUS is organized by Florida Urological Society (FUS) and will be held from Aug 29 - Sep 01, 2019 at Hyatt Regency Grand Cypress, Orlando, Florida, United States of America. This Conference has been approved for a maximum of 16.75 AMA PRA Category 1 Credits™.

Who Should Attend?
The Florida Urological Society 71st Annual Meeting provides continuing medical education for medical students, residents, fellows and practicing physicians in the field of urology. The program applies to physicians with all levels of experience and covers diverse topics relevant to this specialty.

Description:
The field of urology covers a broad spectrum of both benign and malignant diseases of the genitourinary system, including the kidneys, ureters, bladder, prostate, urethra and male external genitalia. Clinical research evidence to guide the evidence-based practice of urology continues to evolve rapidly; however outside CME events, urologists have limited opportunity to familiarize themselves with evolving diagnostic and therapeutic approaches to the disease they treat on a day-to-day basis.

The objectives of this meeting are to provide Florida urologists with a convenient opportunity to educate themselves about the state-of-the art management of urological diseases and engage with expert faculty of national prominence. Particular emphasis will be provided via recommendations from evidence-based clinical practice guidelines as well as continued quality improvement in urological patient care. Specific lecture sessions surrounding the detection and treatment of urologic malignancies will update the urologist on the latest technology available to enhance their clinical practice and outcomes. In addition, focused lectures by national experts will address contemporary issues in voiding dysfunction, reconstruction, infertility, BPH and endourology. Such forums provide an opportunity to disseminate novel techniques and technologies in an evidence-based manner to advance the overall field of knowledge.

The overall goal of the meeting is to provide an evidence-based pathway to discuss the current management of patients suffering from urologic diseases.

Educational Objectives:
At the conclusion of the FUS 71st Annual Meeting, attendees will be able to:
• Discuss the role of the adjustable balloon continence system for the treatment of male stress urinary incontinence.
• Discuss the role of Aquablation for the management of BPH/LUTS.
• Discuss the role of transurethral water vapor therapy for the management of BPH/LUTS.
• Discuss the role of transurethral permanent adjustable transprostatic implants for the management of BPH/LUTS.
• Discuss the role of sacral neuromodulation for the management of voiding dysfunction.
• Describe the role of biomarkers in the evaluation of prostate cancer.
• Discuss management of patients following a negative biopsy in the evaluation of prostate cancer.
• Discuss the potential benefit of MRI in the detection of prostate cancer.
• List options for the timing of repeat prostate biopsy in patients undergoing active surveillance for prostate cancer.
• Define the clinical and pathologic characteristics of high risk prostate cancer.